Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-22 Purchase |
2024-03-26 5:57 pm |
Entrada Therapeutics Inc. | TRDA | KIM PETER S Director |
9,048 | $13.58 | $122,882 | 58,824 (Direct) |
View |
| 2024-03-19 Purchase |
2024-03-21 4:31 pm |
Entrada Therapeutics Inc. | TRDA | KIM PETER S Director |
2,732 | $12.81 | $34,996 | 49,776 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 4:36 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
4,086 | $12.31 | $50,285 | 74,170 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 4:34 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
1,826 | $12.32 | $22,499 | 137,204 (Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 4:37 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO |
1,000 | $15 | $15,000 | 243,279 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:32 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO |
1,000 | $15.99 | $15,990 | 244,279 (Direct) |
View |
| 2023-12-21 Sale |
2023-12-26 4:35 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
12,500 | $15.59 | $194,845 | 216,436 (Direct) |
View |
| 2023-12-20 Sale |
2023-12-22 4:38 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,000 | $15 | $15,000 | 245,279 (Direct) |
View |
| 2023-11-13 Sale |
2023-11-13 4:35 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,000 | $16.23 | $16,230 | 246,279 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-19 5:27 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,000 | $15 | $15,000 | 247,279 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-15 4:21 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,000 | $15 | $15,000 | 248,279 (Direct) |
View |
| 2023-09-06 Sale |
2023-09-06 5:11 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
950 | $13.48 | $12,806 | 71,071 (Direct) |
View |
| 2023-09-06 Sale |
2023-09-06 5:08 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
892 | $13.48 | $12,022 | 61,537 (Direct) |
View |
| 2023-09-06 Sale |
2023-09-06 5:07 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
972 | $13.47 | $13,089 | 69,668 (Direct) |
View |
| 2023-08-14 Sale |
2023-08-16 4:32 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,000 | $15.67 | $15,671 | 201,069 (Direct) |
View |
| 2023-08-02 Sale |
2023-08-04 4:50 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
26,710 | $14.76 | $394,219 | 314,426 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-12 4:34 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
10,000 | $17.99 | $179,862 | 169,945 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-12 4:33 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
7,097 | $18.03 | $127,938 | 35,376 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-12 4:32 pm |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
17,878 | $18.03 | $322,389 | 153,447 (Direct) |
View |
| 2023-06-21 Sale |
2023-06-23 4:20 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
17,500 | $15.01 | $262,648 | 111,404 (Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 4:46 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
15,982 | $15.42 | $246,403 | 42,473 (Direct) |
View |
| 2023-04-27 Sale |
2023-05-01 4:38 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $13.71 | $27,422 | 202,069 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-19 6:07 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,092 | $18.01 | $37,675 | 204,069 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-19 6:06 pm |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
3,961 | $18 | $71,316 | 171,325 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-15 Exercise |
2024-03-19 4:33 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
9,000 | $0 | 126,327 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-19 4:33 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
9,000 | $2.1 | 126,327 (Direct) |
View |
| 2024-03-05 Tax Withholding |
2024-03-05 7:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO |
5,049 | $12.28 | 498,875 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:48 pm |
N/A 2034-03-01 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO |
263,200 | $0 | 498,875 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO |
1,164 | $12.42 | 498,875 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:48 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO |
1,391 | $13.37 | 498,875 (Direct) |
View |
| 2024-03-05 Tax Withholding |
2024-03-05 7:47 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
1,471 | $12.28 | 125,056 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:47 pm |
N/A 2034-03-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
77,700 | $0 | 125,056 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:47 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
339 | $12.42 | 125,056 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:47 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
405 | $13.37 | 125,056 (Direct) |
View |
| 2024-03-05 Tax Withholding |
2024-03-05 7:46 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
1,486 | $12.28 | 189,130 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:46 pm |
N/A 2034-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
143,200 | $0 | 189,130 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:46 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
343 | $12.42 | 189,130 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:46 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO |
409 | $13.37 | 189,130 (Direct) |
View |
| 2024-03-05 Tax Withholding |
2024-03-05 7:44 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
1,505 | $12.28 | 275,832 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:44 pm |
N/A 2034-03-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
110,900 | $0 | 275,832 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:44 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
347 | $12.42 | 275,832 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-05 7:44 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
414 | $13.37 | 275,832 (Direct) |
View |
| 2023-12-21 Exercise |
2023-12-26 4:35 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
12,500 | $0 | 216,436 (Direct) |
View |
| 2023-12-21 Exercise |
2023-12-26 4:35 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
12,500 | $2.1 | 216,436 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 5:12 pm |
N/A 2033-09-01 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
124,900 | $0 | 324,529 (Direct) |
View |
| 2023-09-05 Tax Withholding |
2023-09-06 5:12 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,440 | $14.46 | 324,529 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 5:11 pm |
N/A 2033-09-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
35,700 | $0 | 71,071 (Direct) |
View |
| 2023-09-05 Tax Withholding |
2023-09-06 5:11 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
426 | $14.46 | 71,071 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 5:09 pm |
N/A 2033-09-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
35,700 | $0 | 188,698 (Direct) |
View |
| 2023-09-05 Tax Withholding |
2023-09-06 5:09 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
449 | $14.46 | 188,698 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 5:08 pm |
N/A 2033-09-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
35,700 | $0 | 61,537 (Direct) |
View |
| 2023-09-05 Tax Withholding |
2023-09-06 5:08 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
401 | $14.46 | 61,537 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 5:07 pm |
N/A 2033-09-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
35,700 | $0 | 69,668 (Direct) |
View |
| 2023-09-05 Tax Withholding |
2023-09-06 5:07 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
436 | $14.46 | 69,668 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-05 4:31 pm |
N/A 2033-09-01 |
Entrada Therapeutics Inc. | TRDA | Chapman Gina Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 4:50 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
26,710 | $0 | 314,426 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 4:50 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
26,710 | $2.1 | 314,426 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-12 4:34 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
10,000 | $0 | 169,945 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-12 4:34 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
10,000 | $2.1 | 169,945 (Direct) |
View |
| 2023-06-29 Exercise |
2023-06-30 4:32 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
8,790 | $0 | 111,404 (Direct) |
View |
| 2023-06-29 Exercise |
2023-06-30 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
8,790 | $2.1 | 111,404 (Direct) |
View |
| 2023-06-21 Exercise |
2023-06-23 4:20 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
17,500 | $0 | 111,404 (Direct) |
View |
| 2023-06-21 Exercise |
2023-06-23 4:20 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
17,500 | $2.1 | 111,404 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:06 pm |
N/A 2033-06-08 |
Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:06 pm |
N/A 2033-06-08 |
Entrada Therapeutics Inc. | TRDA | Thistle Mary Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:06 pm |
N/A 2033-06-08 |
Entrada Therapeutics Inc. | TRDA | Crowley John F Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:05 pm |
N/A 2033-06-08 |
Entrada Therapeutics Inc. | TRDA | KIM PETER S Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-03-01 Option Award(A) |
2023-04-19 5:52 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
124,900 | $0 | 281,411 (Direct) |
View |
| 2023-03-01 Option Award(A) |
2023-04-19 5:50 pm |
N/A 2033-03-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
35,700 | $0 | 196,786 (Direct) |
View |